Real World Evidence Scientific Lead

The Real-World Data & Evidence Science (RWD&ES) team serves as an end-to-end strategy and execution partner to solve business problems using real-world data. The Real-World Evidence (RWE) Scientific Lead is responsible for managing the implementation of cutting-edge, effective, and efficient real-world evidence strategy for the development of autoimmune type 1 diabetes (aT1D).

What You Will Do

Manage the end-to-end high-quality execution of real-world studies, working in close partnership with the global RWE Strategy aT1D Lead and internal and external cross-functional collaborators. Deliver strategic scientific input in all stages of RWE study conceptualization through study closure, including study design, cohort construction, protocol & statistical analysis plan development, study operations, data analysis, results interpretation, and clinical study report development.

Why It Might Be a Fit

You are a self-starter who brings your energy, expertise, and experience as well as takes an entrepreneurial approach to solving problems, have a growth mindset, and are passionate about unleashing the power of real-world data with data science to improve health.

Requirements

• Advanced degree in pharmaco-epidemiology, biostatistics, or Health Outcomes (PhD preferred)
• Minimum 5 years in real-world evidence (RWE) generation for pharmaceutical industry with end-to-end leadership experience
• Strong publication track record in relevant journals
• Experience across therapeutic areas, including transplant, diabetes, and cardiovascular
• Expertise in pharmacoepidemiology, HEOR, and RWE study design
• Working with routinely collected healthcare data
• End-to-end project management for real-world studies
• Understanding of commercial strategy
• Fluent English is mandatory, a second European language is appreciated

Benefits

• Thoughtful, well-crafted rewards package
• High-quality healthcare
• Prevention and wellness programs
• At least 14 weeks' gender-neutral parental leave
• Participation in Company employee benefit programs